A point-of-care testing system provides a rapid method for measuring prothrombin time (PT). This device offers individuals on anticoagulant therapy, such as warfarin, a convenient way to monitor their international normalized ratio (INR) at home or in a clinic setting. This technology utilizes a small blood sample, typically from a finger prick, to determine how quickly the blood clots.
Regular monitoring of blood coagulation is critical for patients taking anticoagulants to prevent both thromboembolic events and bleeding complications. The use of such a device enhances patient convenience, potentially leading to improved adherence to medication regimens and better overall health outcomes. Its development has significantly impacted the management of anticoagulation therapy, moving care closer to the patient and reducing the need for frequent laboratory visits.